Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hospitals Struggle To Supply COVID-19 Teams With The Medicines They Need

Executive Summary

Vials arrive in fits and starts, often in wrong sizes, as allocation quotas, quality issues and difficulty anticipating surges wreak havoc in pharmaceutical supply chain.

You may also be interested in...



COVID-19 Shows US FDA Why It Needs To Know Supply Chain’s Current And Surge Capacities

Agency begins gathering manufacturing plant data to prepare for disruptions that can drain inventories over a weekend.

As Other US Agencies Respond To The Pandemic, FEMA Fine-Tunes Plan Of Action

Industry wonders how emergency agency's COVID-19 public-private partnerships will fit in with the others.

USP Building Risk Model To Assess Supply Chain Vulnerabilities And Anticipate Drug Shortages

The USP is developing a risk model to assess whether pharmaceutical supply chains are strong or weak based on demand for reference standards.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS142030

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel